Published on in Vol 22, No 12 (2020): December
1 Department of Haematology, Oncology and Palliative Care, Helios Universitätsklinikum Wuppertal, Wuppertal, Germany
2 The Faculty of Business and Law, Anglia Ruskin University, Cambridge, United Kingdom
3 School of Business, University of Applied Sciences Northwestern Switzerland, Brugg, Switzerland
4 Medical Affairs (Personalised Healthcare and Patient Access), F Hoffmann-La Roche Ltd, Basel, Switzerland
5 Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland
6 Arcondis AG, Reinach, Switzerland
7 Tumor Zentrum Aarau, Hirslanden Klinik Aarau, Aarau, Switzerland
*these authors contributed equally